Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP
Clinical trial NCT05135442 · UNKNOWN
Trial details
- NCT number
- NCT05135442
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.